Marais AD - Search Results

1

Autosomal dominant familial dysbetalipoproteinemia: A pathophysiological framework and practical approach to diagnosis and therapy.

Koopal C, Marais AD, Westerink J, Visseren FL. Koopal C, et al. Among authors: marais ad. J Clin Lipidol. 2017 Jan-Feb;11(1):12-23.e1. doi: 10.1016/j.jacl.2016.10.001. Epub 2016 Oct 13. J Clin Lipidol. 2017. PMID: 28391878 Review.

2

Non-denaturing polyacrylamide gradient gel electrophoresis for the diagnosis of dysbetalipoproteinemia.

Blom DJ, Byrnes P, Jones S, Marais AD. Blom DJ, et al. Among authors: marais ad. J Lipid Res. 2003 Jan;44(1):212-7. doi: 10.1194/jlr.d200013-jlr200. J Lipid Res. 2003. PMID: 12518040 Free article.

3

Screening for dysbetalipoproteinemia by plasma cholesterol and apolipoprotein B concentrations.

Blom DJ, O'Neill FH, Marais AD. Blom DJ, et al. Among authors: marais ad. Clin Chem. 2005 May;51(5):904-7. doi: 10.1373/clinchem.2004.047001. Clin Chem. 2005. PMID: 15855667 No abstract available.

4

Simvastatin with or without ezetimibe in familial hypercholesterolemia.

Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, Gaudet D, Duivenvoorden R, Veltri EP, Marais AD, de Groot E; ENHANCE Investigators. Kastelein JJ, et al. Among authors: marais ad. N Engl J Med. 2008 Apr 3;358(14):1431-43. doi: 10.1056/NEJMoa0800742. Epub 2008 Mar 30. N Engl J Med. 2008. PMID: 18376000 Free article. Clinical Trial.

5

Rosuvastatin reduces non-high-density lipoprotein cholesterol and lipoprotein remnants in patients with dysbetalipoproteinemia (Fredrickson type III hyperlipoproteinemia).

Blom DJ, Marais AD, Retterstøl K, Stein EA, Ycas J, Gu Z, Miller E. Blom DJ, et al. Among authors: marais ad. J Clin Lipidol. 2008 Dec;2(6):418-25. doi: 10.1016/j.jacl.2008.10.002. Epub 2008 Nov 1. J Clin Lipidol. 2008. PMID: 21291775

6

Tendon xanthomas: Not always familial hypercholesterolemia.

Koopal C, Visseren FL, Marais AD, Westerink J, Spiering W. Koopal C, et al. Among authors: marais ad. J Clin Lipidol. 2016 Sep-Oct;10(5):1262-5. doi: 10.1016/j.jacl.2016.05.005. Epub 2016 May 14. J Clin Lipidol. 2016. PMID: 27678445

7

Familial dysbetalipoproteinemia: an underdiagnosed lipid disorder.

Koopal C, Marais AD, Visseren FL. Koopal C, et al. Among authors: marais ad. Curr Opin Endocrinol Diabetes Obes. 2017 Apr;24(2):133-139. doi: 10.1097/MED.0000000000000316. Curr Opin Endocrinol Diabetes Obes. 2017. PMID: 28098593 Review.

8

Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trial.

Koopal C, Marais AD, Westerink J, van der Graaf Y, Visseren FLJ. Koopal C, et al. Among authors: marais ad. J Lipid Res. 2017 Nov;58(11):2180-2187. doi: 10.1194/jlr.M076901. Epub 2017 Sep 19. J Lipid Res. 2017. PMID: 28928170 Free PMC article. Clinical Trial.

9

Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.

Marais AD. Marais AD. Pathology. 2019 Feb;51(2):165-176. doi: 10.1016/j.pathol.2018.11.002. Epub 2018 Dec 28. Pathology. 2019. PMID: 30598326 Review.

10

Comparative aspects of the care of familial hypercholesterolemia in the "Ten Countries Study".

Pang J, Chan DC, Hu M, Muir LA, Kwok S, Charng MJ, Florkowski CM, George PM, Lin J, Loi DD, Marais AD, Nawawi HM, Gonzalez-Santos LE, Su TC, Truong TH, Santos RD, Soran H, Tomlinson B, Yamashita S, Ademi Z, Watts GF. Pang J, et al. Among authors: marais ad. J Clin Lipidol. 2019 Mar-Apr;13(2):287-300. doi: 10.1016/j.jacl.2019.01.009. Epub 2019 Jan 25. J Clin Lipidol. 2019. PMID: 30797720

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page